EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”

.

Bibliographic Details
Main Author: статья Редакционная
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Online Access:https://www.rpcardio.online/jour/article/view/1071
_version_ 1797232245259370496
author статья Редакционная
author_facet статья Редакционная
author_sort статья Редакционная
collection DOAJ
description .
first_indexed 2024-03-08T14:03:19Z
format Article
id doaj.art-a4dfa90a9afe452c9d905d8f57469fd6
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-04-24T15:57:12Z
publishDate 2016-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-a4dfa90a9afe452c9d905d8f57469fd62024-04-01T07:43:32ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-01411070EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”статья Редакционная.https://www.rpcardio.online/jour/article/view/1071
spellingShingle статья Редакционная
EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”
Рациональная фармакотерапия в кардиологии
title EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”
title_full EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”
title_fullStr EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”
title_full_unstemmed EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”
title_short EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”
title_sort editorial comments on the article of m n mamedov and m v stroeva what can we expect using ace inhibitor ramipril in persons with high cardiovascular risk and early disorders of carbohydrate metabolism lessons of dream trial
url https://www.rpcardio.online/jour/article/view/1071
work_keys_str_mv AT statʹâredakcionnaâ editorialcommentsonthearticleofmnmamedovandmvstroevawhatcanweexpectusingaceinhibitorramiprilinpersonswithhighcardiovascularriskandearlydisordersofcarbohydratemetabolismlessonsofdreamtrial